Exploring Racial and Ethnic Differences in Utilization of Medications for Obesity Management in a Nationally Representative Survey
Bibliographic Data
| ID | 2073562 |
|---|---|
| Authors | Kimberly Narain (0000-0001-8548-1728, University of Southern California, corresponding author), Christopher Scannell, Christopher A Scannell (0000-0002-5944-4461, University of Southern California) |
| Year | 2024 |
| Volume | 13 |
| Issue | 1 |
| Pages | 329-339 |
| Publication date | 2024-12-17 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Racial and Ethnic Health Disparities (JOURNAL) |
| Journal identifiers | ISSN: 2196-8837 • E-ISSN: 2197-3792 |
| Publisher | Springer Science and Business Media LLC (PUBLISHER) |
| DOI | 10.1007/s40615-024-02248-x |
| PMID | 39688718 |
| OpenAlex | W4405463209 |
| Language | EN |
| References cited | 33 |
Background The burden of obesity falls disproportionately on some racial and ethnic minority groups. Objective To assess for racial and ethnic differences in the utilization of obesity-management medications among clinically eligible individuals. Design Medical Expenditure Panel Survey (2011-2016, 2018 and 2020) data and a cross-sectional study design was used to assess for racial and ethnic differences in obesity-management medication utilization. Descriptive statistics and multivariable logistic regression models were used to identify the association of race and ethnicity with obesity-management medication utilization. Adjusted models controlled for demographics, socioeconomic status, obesity class, diabetes status, number of chronic conditions, insurance status, and geographic region. Participants Adults with a BMI ≥ 30 kg/m2 and individuals with a BMI ≥ 27 kg/m2 with ≥ 1 weight-related condition. Main Measures The primary outcome measure was utilization of an FDA-approved medication for obesity-management during the study period. The primary independent predictor was race and ethnicity. Separate indicator variables were created for each racial and ethnic group (Non-Hispanic Asian, Non-Hispanic Black, Hispanic, and Non-Hispanic White (reference group)). Key Results In adjusted analyses, Asian (aOR, 0.36; 95% CI, 0.16 to 0.77; P < 0.01), Black (aOR, 0.51; 95% CI, 0.39 to 0.68; P < 0.001) and Hispanic individuals (aOR, 0.70; 95% CI, 0.49 to 0.98; P = 0.04) had significantly lower odds of utilizing obesity-management medications compared to White individuals. Conclusions The results of this study suggest that there are racial and ethnic disparities in the use of obesity-management medications
Body mass index · Cross-sectional study · Environmental health · Ethnic group · Health care · Health insurance · Logistic regression · Medical Expenditure Panel Survey · Obesity · Odds · Odds ratio · Population · Socioeconomic status · Weight loss · Weight management · Demography · Diabetes Treatment and Management · Medicine · Obesity and Health Practices · Pharmacology and Obesity Treatment · Epidemiology · Gerontology · Internal Medicine
| Highly cited | No |
|---|